Digital Biomarkers Market Size, Share & Trends Analysis Report By Product Type (Wearable Application, Mobile Application, Portables), By End-user (Healthcare Companie, Healthcare Services, Others) By Region, And Segment Forecasts, 2022

Description

List of Tables

The digital biomarkers market size was valued at US$2.3 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 25.7% during 2022-2027. The digital biomakers in healthcare market report provides an executive-level overview of the digital biomakers market worldwide today, with detailed forecasts of key indicators up to 2027.

This market intelligence report offers a thorough, forward-looking analysis of the global digital biomarkers market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.

The market is driven by the aging population, increasing investment and funding to develop digital biomarkers, and an increase in M&A and partnership to boost the adoption of biomarkers.

Scope

Overview of digital biomarkers including industry trends, funding & deals, regulatory details, and product & company profile
digital biomarkers market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product type, type, therapeutic area, end-user, and geographic segments.
Digital biomarkers market outlook: analysis as well as forecasts of revenue opportunities from the key end-user segments.
Digital biomarkers in healthcare market outlook: analysis as well as forecasts of revenue opportunities from the type segment.
Digital biomarkers in healthcare market outlook: analysis as well as forecasts of revenue opportunities from the product type segment. Digital biomarkers in healthcare market outlook: analysis as well as forecasts of revenue opportunities from the end-user segment.
The competitive landscape: an examination of the positioning of leading players in digital biomarkers market.

Reasons to Buy

This market intelligence report offers a thorough, forward-looking analysis of the global digital biomarkers market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
Accompanying GlobalData's Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in digital biomarkers markets.
The report also highlights key type, product type, end-user, therapeutic area, and technology segments.
With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in digital biomarkers market.

Product Code: GDPH-SC-MR003

CHAPTER 01 Executive Summary
1.1 Digital Biomarkers Market Snapshot
1.2 Digital Biomarkers Market- Key Findings
CHAPTER 02 Market Landscape
2.1 Market Definition
2.2 Market Scope and Segmentation
2.3 Key Players
- 2.3.1 INDUSTRY PLAYERS
2.4 Industry Trends
- 2.4.1 HEALTHCARE TRENDS
- 2.4.2 TECHNOLOGY TRENDS
- 2.4.3 MACROECONOMIC TRENDS
2.5 Opportunities and Challenges in the Digital Biomarker Space
- 2.5.1 UTILIZING SMARTPHONE-BASED OBJECTIVE MEASUREMENTS OF PHYSICAL FUNCTION
- 2.5.2 SOFTWARE AS A MEDICAL DEVICE (SAMD) AND AI
- 2.5.3 POSTOPERATIVE CARE
- 2.5.4 VOICE AND AUDIO MEASUREMENTS
- 2.5.5 SWEAT ANALYTICS
- 2.5.6 OBJECTIVE MEASUREMENTS IN NEUROLOGY
2.6 Cardiovascular and Metabolic Disease (CVMD)
CHAPTER 03 Digital Biomarkers Value Chain
3.1 Value Chain Analysis
- 3.1.1 FUNCTIONS OF DIGITAL BIOMARKERS
3.2 Devices for Measuring Digital Biomarkers
- 3.2.1 DEVICE LAYER - SENSORS
- 3.2.2 PORTABLE DEVICES
- 3.2.3 WEARABLE DEVICES
- 3.2.4 APP LAYER
CHAPTER 04 Digital Biomarkers Industry Analysis
4.1 Digital Biomarkers Market Structure - PORTER's Analysis
4.2 Deals in Digital Biomarkers
4.3 Funding in Digital Biomarkers
4.4 Partnerships in the Digital Biomarkers
4.5 Timeline of Digital Biomarkers
4.6 Digital Biomarkers Case Studies
- 4.6.1 ROCHE: ONE OF THE LEADING BIOPHARMACEUTICAL COMPANIES IN THE DIGITAL BIOMARKER SPACE IN NEUROLOGY
- 4.6.2 HEARTLINE: APPLE AND JOHNSON & JOHNSON PAVE THE WAY DIGITIZING CLINICAL TRIALS IN CVD
- 4.6.3 FDA APPROVAL OF RESPIRATORY BIOMARKERS
- 4.6.4 INNOVATION CHALLENGES TO ENCOURAGE COLLABORATION AND NEW SOLUTIONS
- 4.6.5 DIGITAL BIOMARKERS HAVE THE POTENTIAL TO TRANSFORM THE DIAGNOSIS OF MENTAL HEALTH
CHAPTER 05 Global Digital Biomarkers Revenue Opportunity
5.1 Global Digital Biomarkers Market
5.2 COVID-19 Pandemic
- 5.2.1 USING DIGITAL BIOMARKERS TO MITIGATE THE IMPACT OF COVID 19 ON CLINICAL TRIALS
CHAPTER 06 Regulatory Overview
6.1 Regulatory Scenario
- 6.1.1 US
- 6.1.2 CANADA
- 6.1.3 EUROPE
- 6.1.4 ASIA-PACIFIC
- 6.1.5 REGULATORY TRENDS
CHAPTER 07 Digital Biomarkers Type Outlook
7.1 Digital Biomarkers - Type Dive
- 7.1.1 MONITORING DIGITAL BIOMARKERS
- 7.1.2 DIAGNOSTICS DIGITAL BIOMARKERS
- 7.1.3 PREDICTIVE DIGITAL BIOMARKERS
- 7.1.4 OTHERS
CHAPTER 08 Digital Biomarkers in Product Type Outlook
8.1 Digital Biomarkers - Product Type Deep Dive
- 8.1.1 WEARABLE APPLICATIONS
- 8.1.2 MOBILE APPLICATIONS
- 8.1.3 PORTABLES
CHAPTER 09 Digital Biomarkers in Therapeutic Area Outlook

9.1.1 NEUROLOGICAL AND MENTAL HEALTH
9.1.2 CARDIOVASCULAR
9.1.3 RESPIRATORY
9.1.4 DIABETIC
9.1.5 OTHERS

CHAPTER 010 Digital Biomarkers End-User Outlook
10.1 Digital Biomarkers - End-User Deep Dive
- 10.1.1 HEALTHCARE COMPANIES
- 10.1.2 HEALTHCARE PROVIDERS
- 10.1.3 OTHERS
CHAPTER 011 Digital Biomarkers Regional Outlook
11.1 Digital Biomarkers - Regional Deep Dive
- 11.1.1 NORTH AMERICA
- 11.1.2 EUROPE
- 11.1.3 ASIA-PACIFIC
- 11.1.4 ROW
CHAPTER 012 Trends, Drivers, and Challenges
12.1 Digital Biomarkers - Market Trends
- 12.1.1 DIGITAL BIOMARKERS HAVE EMERGED AS IMPORTANT PREDICTIVE TOOLS TO SUPPORT THE GLOBAL COVID-19 PANDEMIC
- 12.1.2 DEVELOPMENT OF AI-BASED DIGITAL BIOMARKERS
- 12.1.3 DIGITAL BIOMARKERS AS AN EMERGING TOOL FOR PRECISION MEDICINE
- 12.1.4 GROWING TECHNOLOGY INNOVATIONS
12.2 Digital Biomarkers - Market Drivers
- 12.2.1 AGING POPULATION AND RISE IN CHRONIC DISEASES
- 12.2.2 INCREASING INVESTMENTS AND FUNDING TO DEVELOP DIGITAL BIOMARKERS
- 12.2.3 INCREASE IN M&A AND PARTNERSHIPS TO BOOST THE ADOPTION OF DIGITAL BIOMARKERS
- 12.2.4 INCREASING ROLE OF DIGITAL BIOMARKERS IN CLINICAL TRIALS
12.3 Digital Biomarkers - Market Challenges
- 12.3.1 CHALLENGE TO MAINTAIN DATA SECURITY
- 12.3.2 DATA STANDARDIZATION AND INTERPRETATION ISSUES
- 12.3.3 DIFFICULTIES IN VALIDATION OF BIOMARKERS
CHAPTER 013 Digital Biomarkers Competitive Landscape
CHAPTER 014 Digital Biomarkers Vendor Snapshot

14.1.1 COMPANY SNAPSHOT: ACTIGRAPH, LLC
14.1.2 COMPANY SNAPSHOT: ALIVECOR, INC.
14.1.3 COMPANY SNAPSHOT: BIOGEN INC.
14.1.4 COMPANY SNAPSHOT: AKILI INTERACTIVE LABS INC.
14.1.5 COMPANY SNAPSHOT: EMBIC CORP.
14.1.6 COMPANY SNAPSHOT: FITBIT
14.1.7 COMPANY SNAPSHOT: HAPPIFY HEALTH
14.1.8 COMPANY SNAPSHOT: HUMA
14.1.9 COMPANY SNAPSHOT: IXICO PLC
14.1.10 KONEKSA
14.1.11 MINDSTRONG HEALTH
14.1.12 WINTERLIGHT LABS
14.1.13 CLARIO
14.1.14 IMAGENE AI
14.1.15 BRAINOMIX
14.1.16 KINSA INC.
14.1.17 FEEL THERAPEUTICS

CHAPTER 015 Appendix
15.1 Methodology
15.2 About US
Contact Us

Product Code: GDPH-SC-MR003

List of Tables

Table 1 Key Trends Overview
Table 2 Research Scope and Segmentation
Table 3 The Leaders in Digital Biomarkers
Table 4 Healthcare Trends
Table 5 Technology Trends
Table 6 Macroeconomic Trends
Table 7 Different Uses of Digital Biomarkers
Table 8 M&A in Digital Biomarkers
Table 9 Funding Activity in the Digital Biomarkers Industry
Table 10 Partnership Activity in the Digital Biomarkers Industry
Table 11 Digital Biomarkers Market
Table 12 Fig.11 Digital Biomarkers by Type, 2020-2027 ($Mn)
Table 13 Fig.26 Digital Biomarkers by Product Type, 2020-2027 ($Mn)
Table 14 Fig. Fig.31 Digital Biomarkers by Therapeutic Area, 2020-2027 ($Mn)
Table 15 Fig.39 Digital Biomarkers by End-User, 2020-2027 ($Mn)
Table 16 Digital Biomarkers by Region, 2020-2027 ($Mn)
Table 17 North America Digital Biomarkers by Country, 2020-2027 ($Mn)
Table 18 Europe Digital Biomarkers by Country, 2020-2027 ($Mn)
Table 19 Asia-Pacific Digital Biomarkers by Country, 2020-2027 ($Mn)
Table 20 Technology Innovations by Digital Biomarker Companies
Table 21 Competitive Position of Leading Companies

List of Figures

Figure 1 Market Snapshot ($Mn)
Figure 2 Key Segment Performance Snapshot
Figure 3 Leaders and Challengers in Digital Biomarker Space
Figure 4 Digital Biomarker Value Chain
Figure 5 Different Device Sensors and Functions
Figure 6 Different Device Sensors and Functions
Figure 7 Digital Biomarker Value Chain
Figure 8 Leaders and Challengers in Wearable Technology
Figure 9 Digital Biomarker Value Chain
Figure 10 Digital Biomarker Value Chain
Figure 11 Examples of Skin Patches/Sensors
Figure 12 Examples of Skin Patches/Sensors
Figure 13 Summary of Ingestible Technologies
Figure 14 Examples of Mobile Apps that Can Be Used to Collect Digital Biomarkers
Figure 15 Examples of Companies Developing Software for the Collection and Analysis of Digital Biomarkers
Figure 16 Global Digital Biomarkers PORTER's Five Force Analysis
Figure 17 Timeline of Digital Biomarkers
Figure 18 Global Digital Biomarkers Market - Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 19 Key Findings
Figure 20 Digital Biomarkers by Type- Market Overview ($Mn)
Figure 21 Digital Biomarkers by Type - 2021 & 2027 (%)
Figure 22 Monitoring Digital Biomarkers Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 23 Diagnostics Digital Biomarkers Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 24 Predictive Digital Biomarkers Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 25 Other Types of Digital Biomarkers Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 26 Digital Biomarkers by Product Type- Market Overview ($Mn)
Figure 27 Digital Biomarkers by Product Type Share - 2021 & 2027 (%)
Figure 28 Wearable Applications Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 29 Mobile Applications Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 30 Portables Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 31 Digital Biomarkers by Therapeutic Area- Market Overview ($Mn)
Figure 32 Digital Biomarkers by Therapeutic Area Share - 2021 & 2027 (%)
Figure 33 Neurological and Mental Health Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 34 Cardiovascular Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 35 Respiratory Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 36 Diabetic Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 37 Others Applications Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 38 Digital Biomarkers by End-User - Market Overview ($Mn)
Figure 39 Digital Biomarkers by End-User Share - 2021 & 2027 (%)
Figure 40 Healthcare Companies Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 41 Healthcare Providers Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 42 Others Digital Biomarkers End-User Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 43 Digital Biomarkers by Region- Market Overview ($Mn)
Figure 44 Digital Biomarkers by Region Share - 2021 & 2027 (%)
Figure 45 North America Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 46 Europe Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 47 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 ($Mn)
Figure 48 ROW Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Digital Biomarkers Market Size, Share & Trends Analysis Report By Product Type (Wearable Application, Mobile Application, Portables), By End-user (Healthcare Companie, Healthcare Services, Others) By Region, And Segment Forecasts, 2022 - 2027

Description

Table of Contents

List of Tables

Scope

Reasons to Buy

Table of Contents

Table of Contents

List of Tables

List of Tables

List of Figures

List of Figures